Schacterle Amy

Schacterle Amy is listed in filings as Chief Regulatory Officer at Acumen Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 21, 2026, including sale activity. Recent filings connect the profile to Acumen Pharmaceuticals, Inc. (ABOS). The current snapshot covers public activity from Nov 6, 2024 to Jan 21, 2026. Reported amounts are shown as $1.0M to $2.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.